Piper, Kevin2010-11-022010-11-022010-11-02https://hdl.handle.net/11299/95953The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.This project aims to educate the public about the lack of evidence to support screening the general population for prostate cancer by using blood tests. Simply looking at the financial cost of such screening, one can easily see the great expense in adding just one year to one person’s life. Further review would demonstrate such screening not only is very expensive, but many times causes more harm than good. In a time of great financial difficulty in the United States, it is crucial that the health care industry uses screening techniques that are proven to be cost effective (and improve health outcomes).en-USEconomicProstate Specific AntigenProstate specific antigen (PSA) screening is not a useful tool in screening the general population for prostate cancerOther